http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101942890-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6844 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate | 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101942890-B1 |
| titleOfInvention | Novel Biomarkers for Predicting Susceptibility to EGFR-Targeting Agent and Uses Thereof |
| abstract | The present invention relates to a novel biomarker for predicting susceptibility to an EGFR-target agent and a use thereof. More particularly, the present invention relates to an EGFR (Epidermal Growth Factor Receptor) - biomarkers for predicting susceptibility to target products; Gene expression level of the biomarker; Or a composition for predicting susceptibility to an EGFR-target agent, comprising an agent for measuring the expression or activity level of a protein of said gene; A composition for promoting susceptibility to an EGFR-target agent comprising the expression of the gene or the expression or activity inhibitor of the protein of the gene as an active ingredient; A kit for predicting susceptibility to an EGFR-target formulation comprising said composition; And methods for predicting susceptibility to EGFR-targeted agents. According to the present invention, the present invention is excellent in predicting the susceptibility to an EGFR-target preparation in colorectal cancer, so that the present invention can be usefully used for the treatment of colon cancer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200145358-A |
| priorityDate | 2014-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 559.